Future Financial Wealth Managment LLC Buys New Position in The Cigna Group (NYSE:CI)

Future Financial Wealth Managment LLC purchased a new stake in The Cigna Group (NYSE:CIFree Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 550 shares of the health services provider’s stock, valued at approximately $191,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Strategic Wealth Partners Ltd. boosted its holdings in shares of The Cigna Group by 3.3% during the 3rd quarter. Strategic Wealth Partners Ltd. now owns 1,398 shares of the health services provider’s stock valued at $484,000 after buying an additional 45 shares in the last quarter. Brookstone Capital Management raised its holdings in The Cigna Group by 3.1% in the third quarter. Brookstone Capital Management now owns 1,338 shares of the health services provider’s stock worth $464,000 after buying an additional 40 shares during the last quarter. City Holding Co. lifted its stake in shares of The Cigna Group by 7.4% in the third quarter. City Holding Co. now owns 3,326 shares of the health services provider’s stock worth $1,152,000 after buying an additional 229 shares in the last quarter. Atomi Financial Group Inc. lifted its stake in shares of The Cigna Group by 9.7% in the third quarter. Atomi Financial Group Inc. now owns 1,590 shares of the health services provider’s stock worth $551,000 after buying an additional 140 shares in the last quarter. Finally, Clean Yield Group grew its holdings in shares of The Cigna Group by 6.1% during the third quarter. Clean Yield Group now owns 1,043 shares of the health services provider’s stock valued at $361,000 after buying an additional 60 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CI shares. Stephens reaffirmed an “overweight” rating and issued a $410.00 price objective on shares of The Cigna Group in a research report on Friday, August 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 price target on shares of The Cigna Group in a report on Tuesday, October 1st. Barclays increased their price objective on The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a research report on Friday, August 2nd. StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 2nd. Finally, Jefferies Financial Group boosted their target price on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, September 17th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $392.79.

View Our Latest Research Report on The Cigna Group

Insiders Place Their Bets

In other news, Director William J. Delaney III sold 2,691 shares of The Cigna Group stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $342.68, for a total transaction of $922,151.88. Following the completion of the sale, the director now owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.60% of the stock is owned by insiders.

The Cigna Group Trading Up 1.1 %

The Cigna Group stock opened at $343.93 on Wednesday. The firm has a market capitalization of $97.70 billion, a price-to-earnings ratio of 28.24, a P/E/G ratio of 1.08 and a beta of 0.50. The Cigna Group has a 12-month low of $253.95 and a 12-month high of $370.83. The firm has a 50 day moving average of $348.23 and a 200 day moving average of $344.85. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.73.

The Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, August 1st. The health services provider reported $6.72 earnings per share for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The firm had revenue of $60.52 billion during the quarter, compared to analyst estimates of $58.30 billion. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The business’s quarterly revenue was up 24.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.13 earnings per share. As a group, research analysts predict that The Cigna Group will post 28.48 earnings per share for the current year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 19th. Shareholders of record on Wednesday, September 4th were paid a $1.40 dividend. This represents a $5.60 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend was Wednesday, September 4th. The Cigna Group’s payout ratio is currently 45.98%.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.